Drug Profile
MCS 18
Alternative Names: MCS-18Latest Information Update: 06 Feb 2018
Price :
$50
*
At a glance
- Originator SiNatur
- Class Analgesics; Anti-inflammatories; Antirheumatics
- Mechanism of Action Dendritic cell modulators; TRPV1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Atherosclerosis; Musculoskeletal pain
Most Recent Events
- 17 Jan 2018 Discontinued - Phase-II for Musculoskeletal pain in Germany (Parenteral) (SiNatur pipeline, January 2018)
- 17 Jan 2018 Discontinued - Preclinical for Atherosclerosis in Germany (Parenteral) (SiNatur pipeline, January 2018)